Equities

Nano Mobile Healthcare Inc

VNTH:PKC

Nano Mobile Healthcare Inc

Actions
  • Price (USD)0.0002
  • Today's Change0.000 / -33.33%
  • Shares traded638.08k
  • 1 Year change-53.49%
  • Beta-0.1824
Data delayed at least 15 minutes, as of Jun 14 2024 20:49 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nano Mobile Healthcare, Inc. develops small, hand-held screening devices, which utilize nanotechnology to detect the presence of specific compounds in the breath. The Company’s first products are the convergence of nano-electronics, bio-informatics, and wireless technology. The products are based on patented technology invented by the National Aeronautics and Space Administration (NASA), which is license to Nanobeak, and further sub-licensed to the Company. The Company is focused on its screening for the presence of disease or the use of drugs.

  • Revenue in USD (TTM)0.00
  • Net income in USD-5.46m
  • Incorporated2015
  • Employees3.00
  • Location
    Nano Mobile Healthcare IncONE BOSTON PLACE,, SUITE 2600BOSTON 62108United StatesUSA
  • Phone+1 (617) 336-7100
  • Fax+1 (845) 818-3588
  • Websitehttp://nanomobilehealthcare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Flexpoint Sensor Systems Inc105.69k-784.94k539.90k3.00--2.12--5.11-0.0062-0.00620.00080.0020.0203--3.2835,230.00-15.07-13.69-92.56-43.1268.2885.70-742.68-247.19---5.800.8636---30.08-16.972.47------
Nano Mobile Healthcare Inc0.00-5.46m654.75k3.00---------0.2255-0.22550.00-0.01290.00----0.00-10,475.82-----------------0.3173----------------
SeqLL Inc0.00-5.00m898.33k7.00---------13.49-13.490.00-1.100.00----0.00-84.66-71.97-128.28-106.09--61.01---1,471.82----1.40---100.00---37.43------
Rouchon Industries Inc3.55m96.12k1.49m--15.221.2111.170.42040.00430.00430.15770.0535----------12.59--16.3643.5738.242.714.441.527.190.13870.0014.486.66117.924.5364.73--
3DX Industries Inc395.19k-688.11k1.84m0.00------4.66-0.0182-0.01820.0104-0.06530.4891--16.73---85.16-286.11----92.78---174.12-1,759.99---2.54-----2.83--19.39------
Telkonet Inc8.45m-1.29m2.06m35.00--0.7061--0.2444-0.0044-0.00440.02850.01541.233.985.07---18.71-24.56-36.26-41.2849.7545.83-15.21-23.542.25-52.910.00--34.640.3964-211.35---16.17--
LumiraDx Ltd126.52m-338.03m2.35m1.21k------0.0186-1.08-1.080.4021-1.310.27651.792.44104,557.90-73.83---96.82---80.48---267.03--1.01-10.512.14---39.62---343.67------
Thermogenesis Holdings Inc9.61m-14.75m2.47m25.00--2.53--0.2567-4.99-4.993.140.12260.64423.259.13384,400.00-105.49-78.08-221.76-133.9421.1029.01-163.77-133.660.3739-0.80281.35---9.90-0.4739-59.49--6.96--
Data as of Jun 14 2024. Currency figures normalised to Nano Mobile Healthcare Inc's reporting currency: US Dollar USD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
NVWM LLCas of 31 Mar 202415.00k0.00%
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.